# Post-Market Registry to Evaluate the Safety and Efficacy of the The SUPRAFLEX CRUZ™ Sirolimus Eluting Coronary Stent System in the Treatment of an Octo- and Nonagenerian All-Comer Patient Cohort With Coronary Artery Disease - the Cruz Senior Study

> **NCT04612179** · — · COMPLETED · sponsor: **IHF GmbH - Institut für Herzinfarktforschung** · enrollment: 2017 (actual)

## Conditions studied

- Coronary Disease

## Interventions

- **DEVICE:** The SUPRAFLEX CRUZ™ Sirolimus eluting coronary stent system

## Key facts

- **NCT ID:** NCT04612179
- **Lead sponsor:** IHF GmbH - Institut für Herzinfarktforschung
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-06-23
- **Primary completion:** 2025-06-12
- **Final completion:** 2025-06-12
- **Target enrollment:** 2017 (ACTUAL)
- **Last updated:** 2025-06-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04612179

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04612179, "Post-Market Registry to Evaluate the Safety and Efficacy of the The SUPRAFLEX CRUZ™ Sirolimus Eluting Coronary Stent System in the Treatment of an Octo- and Nonagenerian All-Comer Patient Cohort With Coronary Artery Disease - the Cruz Senior Study". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT04612179. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*